Pre-eclampsia (PE) remains one of the leading causes of maternal and perinatal morbidity and mortality. Current understanding extends beyond the exclusively angiogenic concept and regards the disease as an immunoinflammatory and thrombotic syndrome arising from the interaction of placental ischemia, oxidative stress, e...
Maria V. Tretyakova, S. Morkos, J. Khizroeva et al.· Voprosy ginekologii akušerst...· 0 citations
Background: Endothelial activation and thromboinflammation play an important role in cancer-associated thrombosis. An imbalance between von Willebrand factor (vWF) and its physiological regulator ADAMTS13 may reflect the development of a prothrombotic endothelial state in patients with malignancies. However, the dynami...
A. Vorobev, V. Bitsadze, J. Khizroeva et al.· Biomedicines· 0 citations
Advances in biomarkers, molecular profiling, and artificial intelligence-based predictive tools are expected to further enhance personalized prevention strategies and improve clinical outcomes in patients with hormone-sensitive malignancies.
F. Sorrentino, Laura Vona, L. Nappi et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.